Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin (GSA-Rmax) is useful for judging the safety of hepatic resection

Surgery

Volumn 140, Issue 3, 2006, Pages 379-386

  Kwon, A Hon ^a   Matsui, Yoichi ^a   Kaibori, Masaki ^a   Ha Kawa, Sang Kil ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSYL HUMAN SERUM ALBUMIN TC 99M; INDOCYANINE GREEN; RADIOISOTOPE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; FEMALE; HUMAN; HYPERBILIRUBINEMIA; LIVER; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SAFETY; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEPATECTOMY; HEPATOCYTES; HUMANS; HYPERBILIRUBINEMIA; INDOCYANINE GREEN; LIVER; LIVER FAILURE; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33747366048     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2006.02.011     Document Type: Article

References (41)

1. Lai E.C., Fan S.T., Lo C.M., Chu K.M., Liu C.L., and Wong J. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg 221 (1995) 291-298
2. Torzilli G., Makuuchi M., Inoue K., et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 134 (1999) 984-992
3. Tsao J.I., Loftus J.P., Nagorney D.M., Adson M.A., and Ilstrup D.M. Trends in morbidity and mortality of hepatic resection for malignancy. A matched comparative analysis. Ann Surg 220 (1994) 199-205
4. Midorikawa Y., Kubota K., Takayama T., et al. A comparative study of postoperative complications after hepatectomy in patients with and without chronic liver disease. Surgery 126 (1999) 484-491
5. Redaelli C.A., Dufour J.F., Wagner M., et al. Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg 235 (2002) 77-85
6. Yamanaka N., Okamoto E., Oriyama T., et al. A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg 219 (1994) 342-346
7. Lau H., Man K., Fan S.T., Yu W.C., Lo C.M., and Wong J. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 84 (1997) 1255-1259
8. Kubota K., Makuuchi M., Kusaka K., et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 26 (1997) 1176-1181
9. Miyagawa S., Makuuchi M., Kawasaki S., and Kakazu T. Criteria for safe hepatic resection. Am J Surg 169 (1995) 589-594
10. Vauthey J.N., Chaoui A., Do K.A., et al. Standardized measurement of the future liver remnant prior to extended liver resection. methodology and clinical associations. Surgery 127 (2000) 512-519
11. Ashwell G., and Morell A.G. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol Relat Areas Mol Biol 41 (1974) 99-128
12. Galli G., Maini C.L., Orlando P., et al. A radiopharmaceutical for the study of the liver: 99mTc-DTPA-asialo-orosomucoid, II: human dynamic and imaging studies. J Nucl Med Allied Sci 32 (1988) 117-126
13. 99mTc-GSA) liver scintigraphy. Hepatology 25 (1997) 426-429
14. Kwon A.H., Inoue T., and Ha-Kawa S.K. Characterization of the asialoglycoprotein receptor under hypoxic conditions in primary cultured rat hepatocytes. J Nucl Med 46 (2005) 321-325
15. Anthony P.P., Ishak K.G., Nayak N.C., Poulsen H.E., Scheuer P.J., and Sobin L.H. The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol 31 (1978) 395-414
16. Couinaud C. Surgical anatomy of the liver. Several new aspects. Chirurgie 112 (1986) 337-342
17. The terminology committee of the I.H.P.B.A. The Brisbane 2000 terminology of hepatic anatomy and resections. HPB 2 (2000) 333-339
18. Makuuchi M., Kosuge T., Takayama T., et al. Surgery for small liver cancers. Semin Surg Oncol 9 (1993) 298-304
19. Noun R., Jagot P., Farges O., Sauvanet A., and Belghiti J. High preoperative serum alanine transferase levels. effect on the risk of liver resection in Child grade A cirrhotic patients. World J Surg 21 (1997) 390-395
20. Takenaka K., Kanematsu T., Fukuzawa K., and Sugimachi K. Can hepatic failure after surgery for hepatocellular carcinoma in cirrhotic patients be prevented?. World J Surg 14 (1990) 123-127
21. 99mTc-GSA hepatic scintigraphy. Ann Nucl Med 9 (1995) 229-235
22. Matsui Y., Tu W., Kitade H., et al. Hepatocyte volume as an indicator of hepatic functional reserve in cirrhotic patients with liver tumours. J Gastroenterol Hepatol 11 (1996) 540-545
23. Kwon A.H., Inada Y., Uetsuji S., Yamanura M., Hioki K., and Yamamoto M. Response of fibronectin to liver regeneration after hepatectomy. Hepatology 11 (1990) 593-598
24. Lin T.Y., Lee C.S., Chen C.C., Liau K.Y., and Lin W.S. Regeneration of human liver after hepatic lobectomy studied by repeated liver scanning and repeated needle biopsy. Ann Surg 190 (1979) 48-53
25. Kawasaki T., Moriyasu F., Kimura T., Someda H., Fukuda Y., and Ozawa K. Changes in portal blood flow consequent to partial hepatectomy. Doppler estimation. Radiology 180 (1991) 373-377
26. Hanna S.S., Pagliarello G., and Ing A. Liver blood flow after major hepatic resection. Can J Surg 31 (1988) 363-367
27. Panis Y., McMullan D.M., and Emond J.C. Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection. Surgery 121 (1997) 142-149
28. Shirabe K., Shimada M., Gion T., et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 188 (1999) 304-309
29. Fan S.T., Lai E.C., Lo C.M., Ng I.O., and Wong J. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg 130 (1995) 198-203
30. Rikkers L.F., and Moody F.G. Estimation of functional hepatic mass in resected and regenerating rat liver. Gastroenterology 67 (1974) 691-699
31. Moody F.G., Rikkers L.F., and Aldrete J.S. Estimation of the functional reserve of human liver. Ann Surg 180 (1974) 592-598
32. Kwon A.H., Ha-Kawa S.K., Uetsuji S., Kamiyama Y., and Tanaka Y. Use of technetium 99m diethylenetriamine-pentaacetic acid-galactosyl-human serum albumin liver scintigraphy in the evaluation of preoperative and postoperative hepatic functional reserve for hepatectomy. Surgery 117 (1995) 429-434
33. Namihisa T., Nambu M., Kobayashi N., and Kuroda H. Nine cases with marked retention of indocyanine green test and normal sulfobromophthalein test without abnormal liver histology. constitutional indocyanine green excretory defect. Hepatogastroenterology 28 (1981) 6-12
34. Kilbourn M.R., and Zalutsky M.R. Research and clinical potential of receptor based radiopharmaceuticals. J Nucl Med 26 (1985) 655-662
35. Stadalnik R.C., Vera D.R., and Krohn K.A. Receptor-binding radiopharmaceuticals. Experimental and clinical aspects. In: Freemann L.M., and Weissmann H.S. (Eds). Nuclear medicine annual 1986 (1986), Raven Press, New York 105-139
36. Vera D.R., Stadalnik R.C., and Krohn K.A. Technetium-99m galactosyl-neoglycoalbumin. preparation and preclinical studies. J Nucl Med 26 (1985) 1157-1167
37. Gartner U., Stockert R.J., Morell A.G., and Wolkoff A.W. Modulation of the transport of bilirubin and asialoorosomucoid during liver regeneration. Hepatology 1 (1981) 99-106
38. Meyer B., Luo H.S., Bargetzi M., Renner E.L., and Stalder G.A. Quantitation of intrinsic drug-metabolizing capacity in human liver biopsy specimens. support for the intact-hepatocyte theory. Hepatology 13 (1991) 475-481
39. Stockert R.J., and Morell A.G. Hepatic binding protein. the galactose-specific receptor of mammalian hepatocytes. Hepatology 3 (1983) 750-757
40. Miki K., Kubota K., Inoue Y., Vera D.R., and Makuuchi M. Receptor measurements via Tc-GSA kinetic modeling are proportional to functional hepatocellular mass. J Nucl Med 42 (2001) 733-737
41. Sawamura T., Nakada H., Hazama H., Shiozaki Y., Sameshima Y., and Tashiro Y. Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma. Asiaroglycoprotein receptor in cirrhosis and liver cell carcinoma. Gastroenterology 87 (1984) 1217-1221